New Pharma Companies Research Reports by Global Markets Direct Now Available at MarketPublishers.com

24 Jul 2014 • by Natalie Aster

LONDON - Market Publishers Ltd announces that new Global Markets Direct research reports on pharmaceutical companies have been added to its catalogue.

Phylogica Limited - Product Pipeline Review – 2014. Phylogica Limited is the leading Australian drug discovery firm focused on natural peptides production. The novel report offers an extensive overview of the company’s business, along with its subsidiaries and locations. It includes comprehensive data on Phylogica Limited’s therapeutic developmental pipeline and enlists its key projects. The company’s product portfolio, latest updates and developments are reviewed, too …

Dong Wha Pharma Co., Ltd. - Product Pipeline Review – 2014. The new research study contains an analysis of the South Korea-based pharmaceutical company Dong Wha Pharma Co., Ltd., which is engaged in the manufacturing of drugs for respiratory, cardiovascular and oncology diseases. Furthermore, it features the firm’s products line, their developmental history and provides data on key facts, subsidiaries, projects and locations. A review of the latest news, press releases and updates is given …

Venus Remedies Limited - Product Pipeline Review – 2014. Venus Remedies Limited is a main pharmaceutical firm developing oncology and antibiotics drugs in India. The report provides firm’s description, key data, facts and information. It describes the current Venus Remedies Limited’s human therapeutic developmental pipeline. Main products, latest projects and developments, along with subsidiaries and locations are featured. Data on the latest news and updates is included …

Zyngenia, Inc. - Product Pipeline Review – 2014. The new report presents detailed information on Zyngenia, Inc., the US bio-therapeutics firm concentrated on the antibody drugs developments. It contains deep analysis of the key pharmaceuticals products, projects, developments and milestones. Furthermore, the study includes Zyngenia’s human therapeutic division description. The research covers main subsidiaries, locations and provides latest news and press releases…

Dicerna Pharmaceuticals, Inc. - Product Pipeline Review – 2014. Dicerna Pharmaceuticals, Inc. is the US-headquartered developer of innovative drugs for inherited diseases. The new research gives detailed information on the company’s therapeutic developmental pipeline. It also features products description, along with main projects and milestones. Data on Dicerna Pharmaceuticals’s subsidiaries and locations is featured. In addition, the latest updates and news are overviewed …

More new studies by the publisher can be found at Global Markets Direct page.

CONTACTS

The Market Publishers, Ltd.
Natalie Aster
Tel: +44 208 144 6009
Fax: +44 207 900 3970
ps@marketpublishers.com 
MarketPublishers.com